Market Size of Pharmaceutical Blister Packaging Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 5.62 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Pharmaceutical Blister Packaging Market Analysis
The pharmaceutical blister packaging market is estimated to register a CAGR of 5.62 from 2022 to 2027. The market comprises different packaging solutions, technologies, and components according to the applications. The companies focus on recyclable materials through in-house research, development programs, and collaboration with material providers. Such innovations and the demand for decreasing carbon footprints drive the market.
- Packaging plays an important role in the pharmaceutical industry. The tamper- and damage-free delivery of medicinal products from pharmaceutical manufacturing companies to the patients is achieved by specialized packaging options. Blister packaging is one o those options that keep the therapeutic commodities safe, moisture-free, and protected from as many external contaminants as possible.
- Pharmaceutical packaging has witnessed several options, including stoneware storage, glassware storage (preferred to date for some medicines), and plastic containers and bottles. Blister packaging was picked in the 19th century and has evolved with the needs of the pharmaceutical industry to suit the different applications. The blister packaging can comprise thermoformed plastic with the lid formed out of paper, plastic, foil, or a combination of any of these. Another form of blister packaging prevalent has been the one formed solely from foil, leveraging the cold-stretching process. The opaque alternatives in either provided light-sensitive medicines protection from UV rays.
- Blister packaging proves to be a robust form of packaging and transporting the medical essentials. The packaging protects from blows, wet conditions, and heat, providing better shelf life and transportation abilities of the medicines. Such virtues of blister packaging came into light during the pandemic when the surface of the packaging played a vital role in transporting and storing medications internationally. However, the transfer of the virus through the surface underscored the scope of improvement in the outer materials that the packaging manufacturers will focus on in the coming times.
- The COVID-19 pandemic increased the demand for medicinal products deploying blister packaging but faced issues with the movement of raw materials due to international lockdown restrictions. Many blister packaging players supported the situation by altering the manufacturing processes by adapting to the need of the hour. For instance, Pharmaworks, a ProMach product brand specializing in pharmaceutical blister packaging machinery, donated more than 17,000 face shields to help meet the needs of healthcare professionals and first responders.
Pharmaceutical Blister Packaging Industry Segmentation
Blister packaging refers to the cavity formed in plastic through thermoplastic, according to the medical equipment, tablet, or any other commodity as per its size, covered by a lid to encapsulate it safely. This way of packaging secures the medical item for safe usage, comprising different packaging components. The pharmaceutical blister packaging market is segmented by type (compartment blister packs and slide blister packs), component (films, lidding materials, secondary containers, and packaging accessories), and geography.
| Segmentation - By Type | |
| Compartment Blister Packs | |
| Slide Blister Packs | |
| Other Blister Packs |
| Segmentation - By Component | |
| Films | |
| Lidding Materials | |
| Secondary Containers | |
| Packaging Accessories |
| Segmentation - By Geography | |
| North America | |
| Europe | |
| Asia Pacific | |
| Africa | |
| Rest of the World |
Pharmaceutical Blister Packaging Market Size Summary
The pharmaceutical blister packaging market is experiencing steady growth, driven by the increasing demand for efficient and secure packaging solutions in the pharmaceutical industry. Blister packaging is essential for ensuring the safe, moisture-free, and tamper-proof delivery of medicinal products. This packaging method has evolved significantly since its inception in the 19th century, adapting to the diverse needs of the industry. The market is characterized by a focus on innovation, particularly in the development of recyclable materials and sustainable packaging solutions. Companies are actively engaging in research and development, as well as collaborations with material providers, to reduce carbon footprints and enhance the recyclability of packaging materials. The COVID-19 pandemic further highlighted the importance of blister packaging in maintaining the integrity of medications during transportation, although it also underscored the need for improvements in the materials used to prevent virus transmission.
The market is moderately competitive, with a mix of major and local players offering a variety of packaging solutions and technologies. The increasing global consumption of medicines, coupled with government initiatives promoting bulk drug manufacturing and the use of recyclable materials, is driving the demand for blister packaging. The rise in Active Pharmaceutical Ingredients (APIs) production and the expansion of manufacturing facilities are also contributing to this demand. Companies like Amcor and Klöckner Pentaplast are leading the way in developing innovative, recyclable blister packaging solutions, such as the AmSky system, which eliminates the use of PVC. These advancements are supported by government policies aimed at reducing non-biodegradable plastics and promoting sustainable practices in the pharmaceutical packaging sector. As the industry continues to evolve, the focus on environmentally friendly and efficient packaging solutions is expected to shape the future of the pharmaceutical blister packaging market.
Pharmaceutical Blister Packaging Market Size - Table of Contents
-
1. MARKET INSIGHTS
-
1.1 Market Overview
-
1.2 Industry Attractiveness - Porter's Five Forces Analysis
-
1.2.1 Bargaining Power Of Suppliers
-
1.2.2 Bargaining Power Of Buyers
-
1.2.3 Threat Of New Entrants
-
1.2.4 Threat Of Substitutes
-
1.2.5 Intensity Of Competitive Rivalry
-
-
1.3 Value Chain Analysis
-
1.4 Assessment of the Impact of Covid-19 on the Market
-
-
2. MARKET SEGMENTATION
-
2.1 Segmentation - By Type
-
2.1.1 Compartment Blister Packs
-
2.1.2 Slide Blister Packs
-
2.1.3 Other Blister Packs
-
-
2.2 Segmentation - By Component
-
2.2.1 Films
-
2.2.2 Lidding Materials
-
2.2.3 Secondary Containers
-
2.2.4 Packaging Accessories
-
-
2.3 Segmentation - By Geography
-
2.3.1 North America
-
2.3.2 Europe
-
2.3.3 Asia Pacific
-
2.3.4 Africa
-
2.3.5 Rest of the World
-
-
Pharmaceutical Blister Packaging Market Size FAQs
What is the current Pharmaceutical Blister Packaging Market size?
The Pharmaceutical Blister Packaging Market is projected to register a CAGR of 5.62% during the forecast period (2024-2029)
Who are the key players in Pharmaceutical Blister Packaging Market?
Amkor PLC, Constantia Flexibles GmbH, WestRock Company, Klöckner Pentaplast Group and Honeywell International Inc. are the major companies operating in the Pharmaceutical Blister Packaging Market.
